Gemcitabine: all 1,575 studies that test it

Page 16 of 16. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.

• LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast CancerCompletedNCT00006007Phase 2
• SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid TumorsStatus unknownNCT00005996Phase 1
• Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast CancerCompletedNCT00005991Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung CancerCompletedNCT00005972Phase 2
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerStatus unknownNCT00005958Phase 2
• Gemcitabine, Herceptin and Radiation to Treat Cancer of the PancreasCompletedNCT00005926Phase 2
• Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00005869Phase 3
• Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract CancerCompletedNCT00005831Phase 2
• Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic LeukemiaCompletedNCT00005829Phase 2
• Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic CancerCompletedNCT00005648Phase 3
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionCompletedNCT00005644Phase 2
• Management of Metastatic Breast Cancer in Frail PatientsWithdrawnNCT00005614Phase 2
• Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the PancreasWithdrawnNCT00005591Phase 2
• Gemcitabine in Treating Children With Refractory Solid TumorsCompletedNCT00005577Phase 1
• Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00005093Phase 3
• Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder CancerCompletedNCT00005086Phase 2
• Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00004884Phase 2
• Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic CancerCompletedNCT00004861Phase 2
• Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00004242Phase 1
• Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder CancerCompletedNCT00004223Phase 2
• Oxaliplatin and Gemcitabine in Treating Patients With Advanced CancerCompletedNCT00004220Phase 1
• Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerCompletedNCT00004201Phase 2
• Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung CancerCompletedNCT00004199Phase 3
• Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00004190Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically RemovedCompletedNCT00004160Phase 1/2
• Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid TumorTerminatedNCT00004159Phase 1/2
• Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced CancerCompletedNCT00004144Phase 1
• Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerStatus unknownNCT00004100Phase 3
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck CancerStatus unknownNCT00004097Phase 1
• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00004095Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerTerminatedNCT00004093Phase 1/2
• Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid TumorsCompletedNCT00004090Phase 1
• Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial TumorsCompletedNCT00004082Phase 1
• Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaCompletedNCT00004066Phase 2
• Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced CancerStatus unknownNCT00004063Phase 1/2
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00004003Phase 2
• Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney CancerCompletedNCT00003928Phase 2
• Combination Chemotherapy In Treating Patients With Advanced CancerCompletedNCT00003925Phase 1
• Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic CancerTerminatedNCT00003851Not applicable
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the PancreasCompletedNCT00003810Phase 2
• Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the PancreasStatus unknownNCT00003797Phase 2
• Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the PancreasStatus unknownNCT00003780Phase 2
• Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00003762Phase 2
• Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During SurgeryCompletedNCT00003744Phase 2
• S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by SurgeryCompletedNCT00003723Phase 2
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003707Phase 1
• Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed SurgicallyStatus unknownNCT00003664Phase 2
• S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00003587Phase 2
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00003546Phase 2
• Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and PaclitaxelCompletedNCT00003540Phase 2
• Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell TumorsCompletedNCT00003518Phase 2
• Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian CancerCompletedNCT00003449Phase 2
• Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerStatus unknownNCT00003447Phase 3
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00003426Phase 1
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00003401Phase 2
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00003397Phase 2
• Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube CancerTerminatedNCT00003382Phase 1
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal CancerTerminatedNCT00003378Phase 1
• Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00003358Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney CancerCompletedNCT00003342Phase 1
• Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic CancerCompletedNCT00003332Phase 1/2
• Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the UterusTerminatedNCT00003316Phase 2
• Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck CancerCompletedNCT00003264Phase 2
• Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the PancreasCompletedNCT00003216Phase 3
• Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT00003202Phase 1/2
• Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and NeckStatus unknownNCT00003182Phase 1/2
• Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or StomachCompletedNCT00003157Phase 1
• Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00003144Phase 1
• Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder CancerCompletedNCT00003133Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerCompletedNCT00003105Phase 1/2
• Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00003037Phase 1/2
• Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal CancerStatus unknownNCT00003001Phase 1/2
• Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast CancerCompletedNCT00002998Phase 2
• A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer PatientsCompletedNCT00001449Phase 1
• A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the PancreasCompletedNCT00001431Phase 1

← Gemcitabine overview